Daniel Regan Scheurich, MD in Dallas, TX - Medicare Internal Medicine

Daniel Regan Scheurich, MD is a medicare enrolled "Internal Medicine - Infectious Disease" physician in Dallas, Texas. He went to University Of Illinois College Of Med (chi/peor/rock/chm-urb) and graduated in 2003 and has 21 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice Methodist Inpatient Physicians Llc and his current practice location is 3409 Worth St Ste 710, Dallas, Texas. You can reach out to his office (for appointments etc.) via phone at (214) 823-2533.

Daniel Regan Scheurich is licensed to practice in Texas (license number N4072) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1659396539.

Contact Information

	Daniel Regan Scheurich, MD
	3409 Worth St Ste 710, Dallas, TX 75246-2060
	(214) 823-2533
	(214) 824-8679

Physician's Profile

Full Name	Daniel Regan Scheurich
Gender	Male
Speciality	Internal Medicine
Experience	21 Years
Location	3409 Worth St Ste 710, Dallas, Texas
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Daniel Regan Scheurich attended and graduated from University Of Illinois College Of Med (chi/peor/rock/chm-urb) in 2003

NPI Data:

NPI Number: 1659396539
Provider Enumeration Date: 07/13/2006
Last Update Date: 08/06/2020

Medicare PECOS Information:

PECOS PAC ID: 7810082724
Enrollment ID: I20230209001649

Medical Identifiers

Medical identifiers for Daniel Regan Scheurich such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1659396539	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RI0200X	Internal Medicine - Infectious Disease	2005031081 (Missouri)	Secondary
208M00000X	Hospitalist	2005031081 (Missouri)	Secondary
208M00000X	Hospitalist	28041 (Oklahoma)	Secondary
207RI0200X	Internal Medicine - Infectious Disease	28041 (Oklahoma)	Secondary
207RI0200X	Internal Medicine - Infectious Disease	N4072 (Texas)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Methodist Healthcare Memphis Hospitals	Memphis, TN	Hospital
Greenview Regional Hospital	Bowling green, KY	Hospital
Methodist Hospital	San antonio, TX	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Methodist Inpatient Physicians Llc	1254241235	112

News Archive

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

On behalf of the more than 5 million Americans living with Alzheimer's and their family members, the Alzheimer's Association is encouraged to learn that Biogen will pursue regulatory approval from the FDA for the investigational drug aducanumab based on Phase 3 clinical trial results from the EMERGE and ENGAGE studies, and other related data, after finding a reduction of cognitive and functional decline in people taking the high dose.

Inadequate weight gain during pregnancy puts male fetuses at risk

The amount of weight a woman gains during pregnancy can be vitally important-especially if she's carrying a boy-according to a study by researchers at the University of Georgia released today in PLOS ONE, an open access peer-reviewed journal published by the Public Library of Science.

Pluristem advances toward PLX-PAD Phase IIb clinical trials for CLI and Moderate-severe Claudication

Pluristem Therapeutics Inc. today announced that following its meeting with the Paul Ehrlich Institute (PEI), the German regulatory authority for advanced therapy products (ATP), the company is advancing toward designing two Phase IIb clinical trials for its placenta-derived cell therapy product, PLX-PAD, for the treatment of Critical Limb Ischemia (CLI) and Moderate-severe Claudication.

Interleukin-1 plays major role in wound healing

Anesthesiologists are playing a leading role in research into the molecular factors affecting inflammation, pain, and healing of surgical incisions, as illustrated by papers published in the December issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

Innate immune sensor responding to gut microbes can suppress liver cancer

UT Southwestern researchers have found that a protein in the body's innate immune system that responds to gut microbes can suppress the most common type of liver cancer.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Daniel Regan Scheurich allows following entities to bill medicare on his behalf.

Entity Name	Maury Regional Medical Group, Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1205886264 PECOS PAC ID: 7911810742 Enrollment ID: O20040227000252

News Archive

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

Inadequate weight gain during pregnancy puts male fetuses at risk

Pluristem advances toward PLX-PAD Phase IIb clinical trials for CLI and Moderate-severe Claudication

Interleukin-1 plays major role in wound healing

Innate immune sensor responding to gut microbes can suppress liver cancer

UT Southwestern researchers have found that a protein in the body's innate immune system that responds to gut microbes can suppress the most common type of liver cancer.

Entity Name	Methodist Inpatient Physicians Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1609850692 PECOS PAC ID: 1254241235 Enrollment ID: O20050815000700

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

Inadequate weight gain during pregnancy puts male fetuses at risk

Pluristem advances toward PLX-PAD Phase IIb clinical trials for CLI and Moderate-severe Claudication

Interleukin-1 plays major role in wound healing

Innate immune sensor responding to gut microbes can suppress liver cancer

UT Southwestern researchers have found that a protein in the body's innate immune system that responds to gut microbes can suppress the most common type of liver cancer.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Daniel Regan Scheurich is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Daniel Regan Scheurich, MD 3409 Worth St Ste 710, Dallas, TX 75246-2060 Ph: (214) 823-2533	Daniel Regan Scheurich, MD 3409 Worth St Ste 710, Dallas, TX 75246-2060 Ph: (214) 823-2533

News Archive

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

Inadequate weight gain during pregnancy puts male fetuses at risk

Pluristem advances toward PLX-PAD Phase IIb clinical trials for CLI and Moderate-severe Claudication

Interleukin-1 plays major role in wound healing

Innate immune sensor responding to gut microbes can suppress liver cancer

UT Southwestern researchers have found that a protein in the body's innate immune system that responds to gut microbes can suppress the most common type of liver cancer.

Internal Medicine Doctors in Dallas, TX

Uma B.r.k Pakkivenkata, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 215, Dallas, TX 75231 Phone: 214-396-4950 Fax: 877-423-5360
Dr. Ariel Marcelo Modrykamien, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 960, Dallas, TX 75246 Phone: 402-972-6078
Benjamin Seth Martinez, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3111 Fax: 214-648-5461
Vijaya Mummadi, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 225, Dallas, TX 75231 Phone: 469-646-8880 Fax: 469-646-8884
Dr. Ting-yi Chen, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2800 Fax: 214-645-2808
William Cook Langmade, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1441 N Beckley Ave, Dallas, TX 75203 Phone: 214-947-2306
Dr. Janame J Kottey, MBBS Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 13154 Coit Rd Ste 100, Dallas, TX 75240 Phone: 214-358-2300 Fax: 214-579-6989

Daniel Regan Scheurich, MD - Medicare Internal Medicine in Dallas, TX

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

Inadequate weight gain during pregnancy puts male fetuses at risk

Pluristem advances toward PLX-PAD Phase IIb clinical trials for CLI and Moderate-severe Claudication

Interleukin-1 plays major role in wound healing

Innate immune sensor responding to gut microbes can suppress liver cancer

Medicare Reassignments

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

Inadequate weight gain during pregnancy puts male fetuses at risk

Pluristem advances toward PLX-PAD Phase IIb clinical trials for CLI and Moderate-severe Claudication

Interleukin-1 plays major role in wound healing

Innate immune sensor responding to gut microbes can suppress liver cancer

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

Inadequate weight gain during pregnancy puts male fetuses at risk

Pluristem advances toward PLX-PAD Phase IIb clinical trials for CLI and Moderate-severe Claudication

Interleukin-1 plays major role in wound healing

Innate immune sensor responding to gut microbes can suppress liver cancer

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

Inadequate weight gain during pregnancy puts male fetuses at risk

Pluristem advances toward PLX-PAD Phase IIb clinical trials for CLI and Moderate-severe Claudication

Interleukin-1 plays major role in wound healing

Innate immune sensor responding to gut microbes can suppress liver cancer

Internal Medicine Doctors in Dallas, TX